Home Featured Page 135

Featured

Latest

The Psychedelic Practitioner Issue 6: Preparedness (People)

Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application

Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD

Weekly Psychedelic Policy Briefing – August 9, 2026

Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?

Silo Pharma Announces Stock Repurchase Program

Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical...

Kabir Nath: Our Mission, Progress and Future Perspectives

Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression...

PT385 – Relationships, Conviviality, and The Strength of Empathic Attunement

Kabir Nath: our mission, progress and future perspectives

Late-Stage Psychedelic Trials: A brief review of the two most mature...

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum...

Doing Things Differently: Beyond Business as Usual in the Psychedelics Space

Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining...

EDITOR PICKS

The Psychedelic Practitioner Issue 6: Preparedness (People)

Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application

Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic Practitioner Issue 6: Preparedness (People)

Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application

Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD

Weekly Psychedelic Policy Briefing – August 9, 2026

Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?

Silo Pharma Announces Stock Repurchase Program

Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical...

Kabir Nath: Our Mission, Progress and Future Perspectives

Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression...

PT385 – Relationships, Conviviality, and The Strength of Empathic Attunement

Kabir Nath: our mission, progress and future perspectives

Late-Stage Psychedelic Trials: A brief review of the two most mature...

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum...

Doing Things Differently: Beyond Business as Usual in the Psychedelics Space

Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining...

EDITOR PICKS

The Psychedelic Practitioner Issue 6: Preparedness (People)

Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application

Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY